|
December 5, 2000
PREVACIDŽ (LANSOPRAZOLE) IS FIRST PROTON PUMP INHIBITOR APPROVED FOR HEALING AND RISK REDUCTION OF NSAID-ASSOCIATED GASTRIC ULCERS
November 9, 2000
TAP PHARMACEUTICAL PRODUCTS LICENSES INVESTIGATIONAL ERECTILE DYSFUNCTION COMPOUND FROM FUJISAWA
June 30, 2000
TAP PHARMACEUTICAL PRODUCTS INC. WITHDRAWS NDA FOR UPRIMAŽ (APOMORPHINE HCL TABLETS) SUBLINGUAL
May 24, 2000
TAP PHARMACEUTICAL PRODUCTS INC. ENTERS RESEARCH COLLABORATION
May 23, 2000
TAP PHARMACEUTICAL PRODUCTS INC. PARTNERS WITH AMERICAN GASTROENTEROLOGICAL ASSOCIATION FOR RESEARCH INITIATIVE
|
